Drug-linker constructs bearing unique dual-mechanism tubulin binding payloads tethered through cleavable and non-cleavable linkers

Antibody-drug conjugates (ADCs) have advanced as a mainstay among the most promising cancer therapeutics, offering enhanced antigen targeting and encompassing wide diversity in their linker and payload components. Small-molecule inhibitors of tubulin polymerization have found success as payloads in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Tetrahedron 2025-02, Vol.171, p.134350, Article 134350
Hauptverfasser: Ford, Jacob W., VanNatta, Jennifer M., Mondal, Deboprosad, Lin, Chen-Ming, Deng, Yuling, Bai, Ruoli, Hamel, Ernest, Trawick, Mary Lynn, Pinney, Kevin G.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!